Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-4 of 4

Sort by

Sort Order Select

Journal Articles

Overall Survival with Momelotinib Vs Best Available Therapy in Patients with Ruxolitinib-Experienced Myelofibrosis: A Matching-Adjusted Indirect Comparison

Francesca Palandri, Venediktos Kapetanakis, Balazs Dobi, Filippo Branzanti, Catherine Ellis, Nick Ballew, Tom Liu, Kelesitse Phiri, Fulya Sen Nikitas, Melania Biasi, Shiyuan Zhang, Dwaipayan Patnaik

Blood (2024) 144 (Supplement 1): 3187.

https://doi.org/10.1182/blood-2024-205973

Published: 2024

Journal Articles

Odyssey: A Phase 2 Open-Label Study of Momelotinib in Combination with Luspatercept in Patients with Transfusion-Dependent Myelofibrosis

Prithviraj Bose, Aaron T. Gerds, Vikas Gupta, Bryan Strouse, Bharat Patel, Catherine Ellis, Claire Harrison

Blood (2024) 144 (Supplement 1): 3191.2.

https://doi.org/10.1182/blood-2024-205767

Published: 2024

Journal Articles

Red Blood Cell Transfusion Independence Status Is an Independent Predictor of Survival: A Post Hoc Time-Dependent Analysis of the Phase 3 Simplify-1, Simplify-2, and Momentum Trials

Vikas Gupta, Claire N Harrison, Boris Gorsh, Bharat Patel, Zhaohui Wang, Molly Purser, Catherine Ellis, Bryan Strouse, Dwaipayan Patnaik, Jun Kawashima, Ruben A. Mesa

Blood (2023) 142 (Supplement 1): 3188.

https://doi.org/10.1182/blood-2023-178772

Published: 2023

Journal Articles

Time without Transfusion Reliance or Anemia Worsening: A Novel Method for Integrating Transfusion Dependence, Anemia, and Survival with Myelofibrosis Therapies Based on the Phase 3 Simplify-1 and Simplify-2 Trials

Ruben A. Mesa, Moshe Talpaz, Flora Mazerolle, Boris Gorsh, Manal M'Hari, Antoine Regnault, Catherine Ellis, Zhaohui Wang, Molly Purser, Tom Liu, Bryan Strouse, Dwaipayan Patnaik

Blood (2023) 142 (Supplement 1): 1826.

https://doi.org/10.1182/blood-2023-177784

Published: 2023